NCT03505047 is a NA clinical trial of Copper Intrauterine device in Contraception, sponsored by University of Cape Town.

Who is sponsoring NCT03505047?

NCT03505047 is sponsored by University of Cape Town.

What drugs are being tested in NCT03505047?

Interventions in NCT03505047: Copper Intrauterine device.

What condition does NCT03505047 study?

NCT03505047 studies Contraception.

Is NCT03505047 still recruiting?

NCT03505047 is currently completed. Last updated 26 March 2020.

Last reviewed 2020-03-26 · How we verify

NCT03505047

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immediate Versus Delayed IUD Insertion After Second Trimester Medical Abortion

Completed NA Last updated 26 March 2020

What this trial tests

NA trial testing Copper Intrauterine device in Contraception in 110 participants. Completed in 31 January 2020.

Timeline

10 May 2018

Primary endpoint
31 August 2019

31 January 2020

Quick facts

Lead sponsor	University of Cape Town
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	110
Start date	10 May 2018
Primary completion	31 August 2019
Estimated completion	31 January 2020
Sites	1 location across South Africa

Drugs / interventions tested

Copper Intrauterine device

Conditions studied

Contraception — all drugs for Contraception →

Sponsor

University of Cape Town

Who can join

18 and older, female only, with Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to compare use, in a randomised controlled trial, of the the copper IUD if inserted immediately after completion of a second trimester medical abortion, to standard care with insertion 3-4 or more weeks after abortion at community health centres.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Immediate versus delayed insertion of the copper intrauterine device after medical abortion at 17-20 gestational weeks: a randomised controlled trial.
Constant D, Endler M, Grossman D, Petro G, et al · · 2022 · cited 4× · PMID 33579718 · DOI 10.1136/bmjsrh-2020-200932
Immediate and delayed placement of the intrauterine device after abortion: a systematic review and meta-analysis.
Lou Y, Tang S, Sheng Z, Lian H, et al · · 2024 · PMID 38762680 · DOI 10.1038/s41598-024-62327-1
Immediate IUD insertion after second trimester abortion: implications for service delivery.
Somefun O, Constant D, Endler M. · · 2021 · PMID 34863166 · DOI 10.1186/s12913-021-07306-2
Immediate IUD insertion after second trimester abortion: process evaluation and implications for service delivery
Somefun OD, Constant D, Endler M. · · 2021 · DOI 10.21203/rs.3.rs-279490/v1
Barriers and Facilitators to Immediate Insertion of the Copper IUD after Second-Trimester Medical Abortion - Process Evaluation of A Randomized Controlled Trial
Somefun OD, Constant D, Endler M. · · 2021 · DOI 10.21203/rs.3.rs-164796/v1

Verify or expand the search:

Other recruiting trials for Contraception

Currently open trials in the same condition.

NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive · Phase 2 · recruiting
NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting
NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W · NA · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting

Other University of Cape Town trials

Trials by the same sponsor.

NCT06997328 — '5 Rs to Rescue' A Cluster Trial With an Embedded Process Evaluation · recruiting
NCT06431321 — Evaluation of a 2-session Parent Training Programme for Caregivers of Younger Children in Zimbabwe · NA · not yet recruiting
NCT06051526 — The African Critical Illness Outcomes Study · completed
NCT05723484 — Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection · completed
NCT05681871 — South African Paediatric Surgical Outcomes Study 2 · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03505047 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cape Town
Last refreshed: 26 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03505047.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing